448 related articles for article (PubMed ID: 26100628)
1. From G Protein-coupled Receptor Structure Resolution to Rational Drug Design.
Jazayeri A; Dias JM; Marshall FH
J Biol Chem; 2015 Aug; 290(32):19489-95. PubMed ID: 26100628
[TBL] [Abstract][Full Text] [Related]
2. Novel Allosteric Modulators of G Protein-coupled Receptors.
Gentry PR; Sexton PM; Christopoulos A
J Biol Chem; 2015 Aug; 290(32):19478-88. PubMed ID: 26100627
[TBL] [Abstract][Full Text] [Related]
3. Thematic Minireview Series: New Directions in G Protein-coupled Receptor Pharmacology.
Dohlman HG
J Biol Chem; 2015 Aug; 290(32):19469-70. PubMed ID: 26126823
[TBL] [Abstract][Full Text] [Related]
4. GPCR structures in drug design, emerging opportunities with new structures.
Tautermann CS
Bioorg Med Chem Lett; 2014 Sep; 24(17):4073-9. PubMed ID: 25086683
[TBL] [Abstract][Full Text] [Related]
5. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
Hurevich M; Talhami A; Shalev DE; Gilon C
Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995
[TBL] [Abstract][Full Text] [Related]
6. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
Lu S; Zhang J
J Med Chem; 2019 Jan; 62(1):24-45. PubMed ID: 29457894
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
Grundmann M; Bender E; Schamberger J; Eitner F
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
[TBL] [Abstract][Full Text] [Related]
8. GPCR profiling: from hits to leads and from genotype to phenotype.
Cvijic ME; Sum CS; Alt A; Zhang L
Drug Discov Today Technol; 2015 Nov; 18():30-7. PubMed ID: 26723890
[TBL] [Abstract][Full Text] [Related]
9. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
Persechino M; Hedderich JB; Kolb P; Hilger D
Pharmacol Ther; 2022 Sep; 237():108242. PubMed ID: 35863587
[TBL] [Abstract][Full Text] [Related]
10. Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs.
Congreve M; Oswald C; Marshall FH
Trends Pharmacol Sci; 2017 Sep; 38(9):837-847. PubMed ID: 28648526
[TBL] [Abstract][Full Text] [Related]
11. From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.
Kooistra AJ; Roumen L; Leurs R; de Esch IJ; de Graaf C
Methods Enzymol; 2013; 522():279-336. PubMed ID: 23374191
[TBL] [Abstract][Full Text] [Related]
12. Current and Future Challenges in GPCR Drug Discovery.
Topiol S
Methods Mol Biol; 2018; 1705():1-21. PubMed ID: 29188556
[TBL] [Abstract][Full Text] [Related]
13. Integrated Approaches for Genome-wide Interrogation of the Druggable Non-olfactory G Protein-coupled Receptor Superfamily.
Roth BL; Kroeze WK
J Biol Chem; 2015 Aug; 290(32):19471-7. PubMed ID: 26100629
[TBL] [Abstract][Full Text] [Related]
14. Harnessing Ion-Binding Sites for GPCR Pharmacology.
Zarzycka B; Zaidi SA; Roth BL; Katritch V
Pharmacol Rev; 2019 Oct; 71(4):571-595. PubMed ID: 31551350
[TBL] [Abstract][Full Text] [Related]
15. Class A GPCRs: Structure, Function, Modeling and Structure-based Ligand Design.
Cong X; Topin J; Golebiowski J
Curr Pharm Des; 2017 Nov; 23(29):4390-4409. PubMed ID: 28699533
[TBL] [Abstract][Full Text] [Related]
16. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
Janero DR; Thakur GA
Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
[TBL] [Abstract][Full Text] [Related]
17. Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug Design.
Ciancetta A; Jacobson KA
Methods Mol Biol; 2018; 1705():45-72. PubMed ID: 29188558
[TBL] [Abstract][Full Text] [Related]
18. Potential for the Rational Design of Allosteric Modulators of Class C GPCRs.
Christopher JA; Doré AS; Tehan BG
Curr Top Med Chem; 2017; 17(1):71-78. PubMed ID: 27448651
[TBL] [Abstract][Full Text] [Related]
19. Time-resolved FRET strategy to screen GPCR ligand library.
Oueslati N; Hounsou C; Belhocine A; Rodriguez T; Dupuis E; Zwier JM; Trinquet E; Pin JP; Durroux T
Methods Mol Biol; 2015; 1272():23-36. PubMed ID: 25563174
[TBL] [Abstract][Full Text] [Related]
20. Computational Approaches for the Discovery of GPER Targeting Compounds.
Grande F; Occhiuzzi MA; Lappano R; Cirillo F; Guzzi R; Garofalo A; Jacquot Y; Maggiolini M; Rizzuti B
Front Endocrinol (Lausanne); 2020; 11():517. PubMed ID: 32849301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
